Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Diagnostic Performance of Non-Invasive Tests in Assessing Liver Fibrosis Among Type 2 Diabetes Mellitus

ACTA MEDICA INDONESIANA · Vol. 58 No. 3 (2026)

ISSN
2338-2732, 0125-9326
Terbit
2026-09-28
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng
Lisensi
creativecommons.org/licenses/by/4.0

Abstrak

Background: Noninvasive tools for assessing liver fibrosis are essential, especially in patients with Type 2 Diabetes Mellitus (T2DM) who are at high risk of developing metabolic dysfunction-associated fatty liver disease (MAFLD). This study aimed to evaluate the correlation between the diagnostic accuracy of the Fibrosis-4 Index (FIB-4), aminotransferase-to-platelet ratio index (APRI), and NAFLD fibrosis score (NFS) and the diagnostic accuracy of FibroScan® in Indonesian patients with T2DM. Methods: This cross-sectional study enrolled 80 outpatients with T2DM. Liver fibrosis was evaluated using FibroScan®. FIB-4, APRI, and NFS were calculated using routine clinical and laboratory parameters. Correlations between noninvasive scores and liver stiffness measurement (LSM) were analyzed. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic performance for significant fibrosis (≥F2) and cirrhosis (F3-F4). Results: MAFLD was present in 67.5% of subjects; significant fibrosis and cirrhosis were found in 25% and 7.5% of subjects, respectively. FIB-4 and NFS showed significant correlations with LSM (ρ = 0.291 and 0.296; p < 0.01), whereas APRI did not. FIB-4, APRI, and NFS demonstrated fair to good diagnostic performance for significant fibrosis (area under the curve (AUC) 0.693, 0.685, 0.693) and excellent performance for cirrhosis (AUC 0.825, 0.860, 0.870). Female sex and HOMA-IR were independent predictors of significant fibrosis; AST and platelet count were predictive of cirrhosis. Conclusion: FIB-4, APRI, and NFS are effective and affordable screening tools for initial fibrosis in patients with T2DM, particularly in low-resource settings. The combination of these measures may enhance the detection of at-risk individuals for referral and further management.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 195 tautan kepenulisan bersama · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Herry PurbayuAfiliasi tidak diketahui8
Budi WidodoAfiliasi tidak diketahui8
Ummi MaimunahAfiliasi tidak diketahui7
Iswan Abbas NusiAfiliasi tidak diketahui6
Amie VidyaniAfiliasi tidak diketahui6
Husin ThamrinAfiliasi tidak diketahui6
Yudith Annisa Ayu RezkithaAfiliasi tidak diketahui4
Yoshio YamaokaAfiliasi tidak diketahui4
Ari Fahrial SyamAfiliasi tidak diketahui3
Chyntia Dewi Maharani PutriAfiliasi tidak diketahui3
Iswan A NusiAfiliasi tidak diketahui1
Pangestu AdiAfiliasi tidak diketahui1
Alvin Hartanto KurniawanAfiliasi tidak diketahui1
Benedictus Hanjaya SuwandiAfiliasi tidak diketahui1
Dadang MakmunAfiliasi tidak diketahui1
Manu TandanAfiliasi tidak diketahui1
Raissa Virgy RiandaAfiliasi tidak diketahui1
Mohammad SubkhanAfiliasi tidak diketahui1
Aditya Doni PradanaAfiliasi tidak diketahui1
Fahrun Nisa’i FatimahAfiliasi tidak diketahui1
Rama Azalix RiandaAfiliasi tidak diketahui1
Muhammad Perdana AirlanggaAfiliasi tidak diketahui1
Nitin JagtapAfiliasi tidak diketahui1
Pintu BhakharAfiliasi tidak diketahui1
Yashavanth H SAfiliasi tidak diketahui1
Pankaj ShrimalAfiliasi tidak diketahui1
Mithun SharmaAfiliasi tidak diketahui1
Rajesh GuptaAfiliasi tidak diketahui1
P N RaoAfiliasi tidak diketahui1
D Nageshwar ReddyAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Diagnostic Performance of Non-Invasive Tests in Assessing Liver Fibrosis Among Type 2 Diabetes Mellitus</dc:title>
	<dc:creator>Mufida, Annisa Zahra</dc:creator>
	<dc:creator>Hidayat, Amal Arifi </dc:creator>
	<dc:creator>Alfaray, Ricky Indra </dc:creator>
	<dc:creator>Kholili, Ulfa</dc:creator>
	<dc:creator>Wibisono, Sony</dc:creator>
	<dc:creator>Sugihartono, Titong</dc:creator>
	<dc:creator> Mudjari, Nurike Setiyari</dc:creator>
	<dc:creator>Adiwinoto, Robert Dwitama</dc:creator>
	<dc:creator>Kurniawati, Febri</dc:creator>
	<dc:creator>Miftahussurur, Muhammad</dc:creator>
	<dc:subject xml:lang="en-US">Type 2 Diabetes Mellitus</dc:subject>
	<dc:subject xml:lang="en-US">fibrosis</dc:subject>
	<dc:subject xml:lang="en-US">non-alcoholic fatty liver disease (NAFLD)</dc:subject>
	<dc:subject xml:lang="en-US">Liver cirrhosis</dc:subject>
	<dc:subject xml:lang="en-US">Diagnostic accuracy</dc:subject>
	<dc:description xml:lang="en-US">Background: Noninvasive tools for assessing liver fibrosis are essential, especially in patients with Type 2 Diabetes Mellitus (T2DM) who are at high risk of developing metabolic dysfunction-associated fatty liver disease (MAFLD). This study aimed to evaluate the correlation between the diagnostic accuracy of the Fibrosis-4 Index (FIB-4), aminotransferase-to-platelet ratio index (APRI), and NAFLD fibrosis score (NFS) and the diagnostic accuracy of FibroScan® in Indonesian patients with T2DM. Methods: This cross-sectional study enrolled 80 outpatients with T2DM. Liver fibrosis was evaluated using FibroScan®. FIB-4, APRI, and NFS were calculated using routine clinical and laboratory parameters. Correlations between noninvasive scores and liver stiffness measurement (LSM) were analyzed. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic performance for significant fibrosis (≥F2) and cirrhosis (F3-F4). Results: MAFLD was present in 67.5% of subjects; significant fibrosis and cirrhosis were found in 25% and 7.5% of subjects, respectively. FIB-4 and NFS showed significant correlations with LSM (ρ = 0.291 and 0.296; p &amp;lt; 0.01), whereas APRI did not. FIB-4, APRI, and NFS demonstrated fair to good diagnostic performance for significant fibrosis (area under the curve (AUC) 0.693, 0.685, 0.693) and excellent performance for cirrhosis (AUC 0.825, 0.860, 0.870). Female sex and HOMA-IR were independent predictors of significant fibrosis; AST and platelet count were predictive of cirrhosis. Conclusion: FIB-4, APRI, and NFS are effective and affordable screening tools for initial fibrosis in patients with T2DM, particularly in low-resource settings. The combination of these measures may enhance the detection of at-risk individuals for referral and further management.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2026-09-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/3071</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 58 No. 3 (2026): Acta Medica Indonesiana; 326</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/3071/882</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2026 Annisa Zahra Mufida, Amal Arifi  Hidayat, Ricky Indra  Alfaray, Ulfa Kholili, Sony Wibisono, Titong Sugihartono, Nurike Setiyari  Mudjari, Robert Dwitama Adiwinoto, Febri Kurniawati, Muhammad Miftahussurur</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>